Sorrento Therapeutics, Inc. announced the unexpected passing of Mr. Najjam Asghar, Senior Vice President. Mr. Asghar died of apparent natural causes on January 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0135 USD | +12.50% | -32.50% | -89.07% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-89.07% | 6.52M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Sorrento Therapeutics, Inc. Announces Demise of Najjam Asghar, Senior Vice President